» Articles » PMID: 2065352

Neonatal Lethality and Lymphopenia in Mice with a Homozygous Disruption of the C-abl Proto-oncogene

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 1991 Jun 28
PMID 2065352
Citations 464
Authors
Affiliations
Soon will be listed here.
Abstract

The c-abl proto-oncogene, which encodes a cytoplasmic protein-tyrosine kinase, is expressed throughout murine gestation and ubiquitously in adult mouse tissues. However, its levels are highest in thymus, spleen, and testes. To examine the in vivo role of c-abl, the gene was disrupted in embryonic stem cells, and the resulting genetically modified cells were used to establish a mouse strain carrying the mutation. Most mice homozygous for the c-abl mutation became runted and died 1 to 2 weeks after birth. In addition, many showed thymic and splenic atrophy and a T and B cell lymphopenia.

Citing Articles

Grb7, Grb10 and Grb14, encoding the growth factor receptor-bound 7 family of signalling adaptor proteins have overlapping functions in the regulation of fetal growth and post-natal glucose metabolism.

Moorwood K, Smith F, Garfield A, Cowley M, Holt L, Daly R BMC Biol. 2024; 22(1):221.

PMID: 39343875 PMC: 11441139. DOI: 10.1186/s12915-024-02018-5.


BCR::ABL1 Proteolysis-targeting chimeras (PROTACs): The new frontier in the treatment of Ph leukemias?.

Cruz-Rodriguez N, Tang H, Bateman B, Tang W, Deininger M Leukemia. 2024; 38(9):1885-1893.

PMID: 39098922 PMC: 11569815. DOI: 10.1038/s41375-024-02365-w.


ABL1-mediated phosphorylation promotes FOXM1-related tumorigenicity by Increasing FOXM1 stability.

Dong Q, Wang D, Song C, Gong C, Liu Y, Zhou X Cell Death Differ. 2024; 31(10):1285-1301.

PMID: 39060421 PMC: 11445503. DOI: 10.1038/s41418-024-01339-w.


Human ABL1 deficiency syndrome (HADS) is a recognizable syndrome distinct from ABL1-related congenital heart defects and skeletal malformations syndrome.

AlAbdi L, Neuhann T, Prott E, Schon U, Abdulwahab F, Faqeih E Hum Genet. 2024; 143(6):739-745.

PMID: 38743093 DOI: 10.1007/s00439-024-02677-y.


ABL1 kinase as a tumor suppressor in AML1-ETO and NUP98-PMX1 leukemias.

Golovine K, Abalakov G, Lian Z, Chatla S, Karami A, Chitrala K Blood Cancer J. 2023; 13(1):42.

PMID: 36959186 PMC: 10036529. DOI: 10.1038/s41408-023-00810-0.